NCT07693751
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07693751
Title A Study Testing SOT109 for the First Time in Patients, to Assess How Safe SOT109 is, How Well it Works, and How the Body Handles it in Patients With Advanced Colorectal Cancer That Can Not be Removed by Surgery or is Metastatic
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors SOTIO Biotech a.s.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
NEXT Houston Houston Texas 77054 United States Details
NEXT Virginia Faifax Virginia 22031 United States Details
Arensia Exploratory Medicine Research Unit, Institute of Oncology Chisinau Moldova Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field